The present study confirmed the upregulation of SERPINA3 in DCI samples, which corresponds to the combined state of elevated systemic inflammatory levels, increased insulin resistance, and impaired cerebral microvascular function in patients with type 2 diabetes mellitus. Here, SERPINA3 is linked to Insulin resistance.